Stanozolol 50 - Livewell Pharmaceuticals

With a clinical launch in 1962, Stanozolol gained rapid acceptance as Winstrol, a compound developed to treat wasting diseases and hormonal growth deficiencies. Created by Winthrop and patented by Sterling, it was among the first DHT derivatives to be orally active. Its structural modification via a pyrazole group made it unique among steroids. Though its approval narrowed over time, it found long-term use in both humans and animals. Even after U.S. production ceased, foreign labs continued manufacture for approved veterinary and therapeutic purposes.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Stanozolol 50 by Livewell Pharmaceuticals, consult with your doctor or healthcare professional.